Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas- mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients

AIDS Research and Human Retroviruses

Volumn 14, Issue 3, 1998, Pages 261-267

  Arai, Masaaki ^a   Kannagi, Mari ^a   Matsuoka, Masao ^b   Sato, Takaaki ^c   Yamamoto, Naoki ^a   Fujii, Masahiro ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; FAS ASSOCIATED PHOPHATASE; MONOCLONAL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL LINE; CELL VIABILITY; DISEASE ASSOCIATION; DNA DAMAGE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; IMMUNOSURVEILLANCE; NORTHERN BLOTTING; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; T CELL LEUKEMIA; T LYMPHOCYTE;

EID: 0032501983     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.261     Document Type: Article

References (40)

1. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, and Miyoshi I: Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981;78:6476-6480.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, and Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultures lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
3. Osame M, Igata A, Usuku K, Rosales RL, and Matsumoto M: HTLV-I-associated myelopathy, a new clinical entity. Lancet 1986;i:1031.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, and de Thé G: Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985;ii:407.
5. Yoshida M, Suzuki T, Fujisawa J, and Hirai H: HTLV-1 oncoprotein tax and cellular transcription factors. Curr Topics Microbiol Immunol 1995;193:79-89.
6. Sugamura K and Hinuma Y: Human retroviruses: HTLV-I and HTLV-II. In: The Retroviridae (Levy JA, ed.), Vol. 2. Plenum Press, New York, 1993, pp. 399-435.
7. Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, and Yoshiki T: A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 1992;176:981-989.
8. Ijichi S, Nakagawa M, Umehara F, Higuchi I, Arimura K, Izumo S, and Osame M: HAM/TSP: Recent perspectives in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:S26-S32.
9. Tendler CL, Greenberg SJ, Burton JD, Danielpour D, Kim SJ, Blattner WA, Manns A, and Waldmann TA: Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: Alternate molecular mechanisms underlying retroviral pathogenesis. J Cell Biochem 1991;46:302-311.
10. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, and Osame M: Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994;53: 72-77.
11. Osame M, Matsumoto M, Usuku K, Izumo S, Ijichi N, Amitani H, Tara M, and Igata A: Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cells leukemia-like cells. Ann Neurol 1987;23:117.
12. Usuku K, Sonoda S, Osame M, Yashiki S, Takahashi K, Matsumoto M, Sawada T, Tsuji K, Tara M, and Igata A: HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988;S143-S150.
13. Vermant JC, Buisson G, Magdeleine J, DeThore J, Jouannelle A, Neisson-Vernant C, and Monplaisir N: T-lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren syndrome. Lancet 1988;i:177.
14. Phillips PE, Johnson SL, Runge LA, Moore JL, and Poiesz BJ: High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus. J Clinic Immunol 1986;6:234-241.
15. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hatanaka M, Yamamoto H, and Sekiguchi T: Induction of inflammatory arthropathy resembling rhematoid arthritis in mice transgenic for HTLV-I. Science 1991;253:1026-1028.
16. Green JE, Hinrichs SH, Vogel J, and Jay G: Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (London) 1989;341:72-74.
17. Iwakura Y, Saijo S, Kioka Y, Nakayama-Yamada J, Itagaki K, Tosu M, Asano M, Kanai Y, and Kakimoto K: Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J Immunol 1995;155:1588-1598.
18. Yonehara S, Ishii A, and Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen Co-downregulated with the receptor of a tumor necrosis factor. J Exp Med 1989;169: 1747-1756.
19. Trauth BC, KIas C, Peters AM, Matzku S, Moller P, Falk W, Debatin KM, and Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245: 301-305.
20. Nagata S and Golstein P: The Fas death factor. Science 1995; 267:1449-1456.
21. Watanabe FR, Brannan CI, Copeland NG, Jenkins NA, and Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 1992;356:314-317.
22. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, and Heeney JL: Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses 1994;10:1259-1268.
23. Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M, and Hinuma Y: Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int J Cancer 1984;34:221-228.
24. Ohtani K, Nakamura M, Saito S, Nagata K, Sugamura K, and Hinuma Y: Electroporation: Application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res 1989;17:1589-1604.
25. Takahashi S, Sato N, Takayama S, Ichimiya S, Satoh M, Hyakumachi N, and Kikuchi K: Establishment of apoptosis-inducing monoclonal antibody 2D1 and 2D1-resistant variants of human T cell lines. Eur J Immunol 1993;23:1935-1941.
26. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 1993;15:532-534.
27. Maekawa K, Imagawa N, Nagamatsu M, and Harada S: Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett 1994; 337:200-206.
28. Sato T, Irie S, Kitada S, and Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-415.
29. Itoh N, Tsujimoto Y, and Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627.
30. Miyazaki T, Liu Z-J, Kawahara A, Minami Y, Yamada K, Tsujimoto Y, Barsoumian EL, Perlmutter RM, and Taniguchi T: Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 1995;81: 223-231.
31. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S, and Taniguchi T: An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (London) 1995;376:595-599.
32. Kishi S, Saijyo S, Arai M, Karasawa S, Ueda S, Kannagi M, Iwakura Y, Fujii M, and Yonehara S: Resistance to Fas-mediated apoptosis of peripheral T-cell sin HTLV-I transgenic mice with autoimmune arthropathy. J Exp Med 1997;186:57-64.
33. Mori S, Murakami MK, Jewett A, Nakamura S, and Bonavida B: Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res 1996;56:1874-1879.
34. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, and Swain SL: Unequal death in T helper cell (Th)1 and Th2 effectors: th1, but not th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997;185:1837-1849. [In process citation]
35. Yanagisawa J, Takahashi M, Kanki H, Yano YH, Tazunoki T, Sawa E, Nishitoba T, Kamishohara M, Kobayashi E, Kataoka S, and Sato T: The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 1997;272:8539-8545.
36. Furukawa Y, Osame M, Kubota R, Tara M, and Yoshida M: Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995;85:1865-1870.
37. Nagata S and Suda T: Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995;16:39-43.
38. Rieux LF, Le DF, Hivroz C, Roberts IA, Debatin KM, Fischer A, and de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;2685: 1347-1349.
39. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, and Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-946.
40. Debatin KM, Goldmann CK, Bamford R, Waldmann TA, and Krammer PH: Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 1990;335:497-500.